Literature DB >> 28243782

Pulmonary hypertension and echocardiogram parameters in obstructive sleep apnea.

H T Wong1, K H Chee2, A W Chong3.   

Abstract

Obstructive sleep apnea (OSA) is a growing health hazard in the United States and worldwide. OSA is now recognized as a disorder with systemic manifestations and its association with obesity and adverse cardiovascular consequences. There is increasing evidence that OSA may be associated with systemic hypertension and an increased incidence of stroke, heart failure, myocardial infarction, and arrhythmias. Less information is available about the association between OSA and pulmonary hypertension (PH). We therefore conduct this study to look at the prevalence of the pulmonary hypertension in obstructive sleep apnea patient and to identify risk factors leading to pulmonary hypertension among OSA patient. We studied and analyzed all OSA patient confirmed by polysomnograph in the year 2015. Twenty-five patients with OSA were included in this study with prevalence of pulmonary hypertension of 16%. Univariate analysis of various factors revealed a statistically significant association between having the lowest SpO2 of <70% and pulmonary hypertension (p = 0.016). There were no statistically significant associations between age, gender, smoking status, hypertension, body mass index (BMI), or apnea-hypopnea index (AHI) with occurrence of pulmonary hypertension. AHI is not a good predictor for pulmonary hypertension. The real value of using AHI to predict the health risk of OSA is doubtful. We recommend routine echocardiogram among OSA patient. The objective information in the echocardiogram provides evidence for counseling of patient with disease of OSA and hence hopefully can improve compliance of patient to treatment especially usage of CPAP.

Entities:  

Keywords:  Cardiovascular disease; Echocardiography; Obstructive sleep apnea; Pulmonary hypertension

Mesh:

Substances:

Year:  2017        PMID: 28243782     DOI: 10.1007/s00405-017-4491-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  32 in total

Review 1.  Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences.

Authors:  R Kessler; A Chaouat; E Weitzenblum; M Oswald; M Ehrhart; M Apprill; J Krieger
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

2.  Pulmonary arterial hypertension in patients with sleep apnoea syndrome.

Authors:  E Bady; A Achkar; S Pascal; E Orvoen-Frija; J P Laaban
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

3.  Effect of CPAP on oxidative stress and circulating progenitor cell levels in sleep patients with apnea-hypopnea syndrome.

Authors:  Mora Murri; Regina García-Delgado; José Alcázar-Ramírez; Ana Fernández-Ramos; Juan Alcaide; Fernando Cardona; Francisco J Tinahones
Journal:  Respir Care       Date:  2011-05-20       Impact factor: 2.258

4.  Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics.

Authors:  M Alchanatis; G Tourkohoriti; S Kakouros; E Kosmas; S Podaras; J B Jordanoglou
Journal:  Respiration       Date:  2001       Impact factor: 3.580

5.  Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome.

Authors:  Omar A Minai; Basma Ricaurte; Roop Kaw; Jeff Hammel; Mary Mansour; Kevin McCarthy; Joseph A Golish; James K Stoller
Journal:  Am J Cardiol       Date:  2009-11-01       Impact factor: 2.778

Review 6.  [Mechanisms of cardiovascular co-morbidity in patients with obstructive sleep apnoea syndrome].

Authors:  M Meier; S Andreas
Journal:  Pneumologie       Date:  2012-11-06

7.  Cardiac hypertrophy in obstructive sleep apnea syndrome.

Authors:  A Noda; T Okada; F Yasuma; N Nakashima; M Yokota
Journal:  Chest       Date:  1995-06       Impact factor: 9.410

8.  Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Carlos Zamarrón; Luis Valdés Cuadrado; Rodolfo Alvarez-Sala
Journal:  Pulm Med       Date:  2013-06-27

9.  Early left ventricular systolic and diastolic dysfunction in patients with newly diagnosed obstructive sleep apnoea and normal left ventricular ejection fraction.

Authors:  Lisulov Popovic Danica; Mirjana Krotin; Marija Zdravkovic; Ivan Soldatovic; Darko Zdravkovic; Milica Brajkovic; Vera Gardijan; Jelena Saric; Ruzica Pokrajac; Dragan Lovic; Predrag Stevanovic; Milina Tancic Gajic; Miodrag Vukcevic
Journal:  ScientificWorldJournal       Date:  2014-02-27

10.  Is obstructive sleep apnea associated with cardiovascular and all-cause mortality?

Authors:  Xiahui Ge; Fengfeng Han; Yanxi Huang; Yue Zhang; Tianyun Yang; Chong Bai; Xuejun Guo
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more
  1 in total

1.  Adiponectin ameliorates lung injury induced by intermittent hypoxia through inhibition of ROS-associated pulmonary cell apoptosis.

Authors:  Wenxiao Ding; Xilong Zhang; Qiang Zhang; Yanbin Dong; Wenjing Wang; Ning Ding
Journal:  Sleep Breath       Date:  2020-05-26       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.